Author:
Beimler J.,Morath C.,Zeier M.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. 2011 Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant data 1994-2011. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI
2. Alloway R, Steinberg S, Khalil K et al (2007) Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. Transplantation 83:1648–1651
3. Bloom RD, Reese PP (2007) Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol 18:3031–3041
4. Budde K, Becker T, Arns W et al (2011) Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet 377: 837–847
5. Eisen HJ, Tuzck EM, Dorent R et al (2003) Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349:847–858
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献